Literature DB >> 33674997

Authors' Reply to Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".

Edward E Neuberger1, Josh J Carlson2, David L Veenstra2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33674997     DOI： 10.1007/s40273-021-01006-9

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

1.  Comment on "Cost-Effectiveness of Cannabidiol Adjunct Therapy Versus Usual Care for the Treatment of Seizures in Lennox-Gastaut Syndrome".

Authors:  Kelly Hollenack; Jade Marshall
Journal:  Pharmacoeconomics       Date:  2021-03-06       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.